Tumor necrosis factor receptor and Fas signaling mechanisms
- PMID: 10358762
- DOI: 10.1146/annurev.immunol.17.1.331
Tumor necrosis factor receptor and Fas signaling mechanisms
Abstract
Four members of the tumor necrosis factor (TNF) ligand family, TNF-alpha, LT-alpha, LT-beta, and LIGHT, interact with four receptors of the TNF/nerve growth factor family, the p55 TNF receptor (CD120a), the p75 TNF receptor (CD120b), the lymphotoxin beta receptor (LT beta R), and herpes virus entry mediator (HVEM) to control a wide range of innate and adaptive immune response functions. Of these, the most thoroughly studied are cell death induction and regulation of the inflammatory process. Fas/Apo1 (CD95), a receptor of the TNF receptor family activated by a distinct ligand, induces death in cells through mechanisms shared with CD120a. The last four years have seen a proliferation in knowledge of the proteins participating in the signaling by the TNF system and CD95. The downstream signaling molecules identified so far--caspases, phospholipases, the three known mitogen activated protein (MAP) kinase pathways, and the NF-kappa B activation cascade--mediate the effects of other inducers as well. However, the molecules that initiate these signaling events, including the death domain- and TNF receptor associated factor (TRAF) domain-containing adapter proteins and the signaling enzymes associated with them, are largely unique to the TNF/nerve growth factor receptor family.
Similar articles
-
Structural and biological features of the TNF receptor and TNF ligand superfamilies: interactive signals in the pathobiology of Hodgkin's disease.Ann Oncol. 1996;7 Suppl 4:19-26. doi: 10.1093/annonc/7.suppl_4.s19. Ann Oncol. 1996. PMID: 8836404 Review.
-
Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system.Eur Cytokine Netw. 1995 Mar-Apr;6(2):83-96. Eur Cytokine Netw. 1995. PMID: 7578992 Review.
-
Mechanism of chronic obstructive uropathy: increased expression of apoptosis-promoting molecules.Kidney Int. 2000 Oct;58(4):1481-91. doi: 10.1046/j.1523-1755.2000.00310.x. Kidney Int. 2000. PMID: 11012883
-
Structural determinants of DISC function: new insights into death receptor-mediated apoptosis signalling.Pharmacol Ther. 2013 Nov;140(2):186-99. doi: 10.1016/j.pharmthera.2013.06.009. Epub 2013 Jul 8. Pharmacol Ther. 2013. PMID: 23845861 Review.
-
Intracellular signals and events activated by cytokines of the tumor necrosis factor superfamily: From simple paradigms to complex mechanisms.Int Rev Cytol. 2006;252:129-61. doi: 10.1016/S0074-7696(06)52002-9. Int Rev Cytol. 2006. PMID: 16984817 Review.
Cited by
-
Determination of functional similarity of biosimilar H9P2S from an investigational CHO clone with Adalimumab.3 Biotech. 2022 Nov;12(11):315. doi: 10.1007/s13205-022-03384-z. Epub 2022 Oct 8. 3 Biotech. 2022. PMID: 36276478 Free PMC article.
-
Regulation of chemokine expression by antiinflammatory cytokines.Immunol Res. 2002;25(3):229-45. doi: 10.1385/IR:25:3:229. Immunol Res. 2002. PMID: 12018462 Review.
-
Apoptosis modulates protective immunity to the pathogenic fungus Histoplasma capsulatum.J Clin Invest. 2005 Oct;115(10):2875-85. doi: 10.1172/JCI25365. Epub 2005 Sep 8. J Clin Invest. 2005. PMID: 16151533 Free PMC article.
-
Infliximab for diabetic macular edema refractory to laser photocoagulation: a randomized, double-blind, placebo-controlled, crossover, 32-week study.Diabetes Care. 2010 Jul;33(7):1523-8. doi: 10.2337/dc09-2372. Epub 2010 Apr 22. Diabetes Care. 2010. PMID: 20413522 Free PMC article. Clinical Trial.
-
Controlling Cancer Cell Death Types to Optimize Anti-Tumor Immunity.Biomedicines. 2022 Apr 22;10(5):974. doi: 10.3390/biomedicines10050974. Biomedicines. 2022. PMID: 35625711 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous